Creating a pipeline from diagnosis to drug design, testing, to patient

Precision Nanomedicine at AIBN

AIBN is revolutionising the way the world understands, diagnoses and treats disease by designing nanotechnologies to pioneer personalised medical breakthroughs.

Precision nanomedicine moves away from a one size fits all approach to focus on how diseases develop differently and respond to treatment depending on genes, lifestyle
or environment.

We examine individual molecules, manufacture proteins and use the study of bioinformatics to develop treatments getting them from the lab bench to the clinic more quickly than ever.

Stay up to date with the latest precision nanomedicine news

Stay on top of our industry news and developments, events and opportunities, by joining The Network

Organoids: Tiny organs shaping modern medicine

From neurodegenerative disorders like Alzheimer’s and Parkinson’s to cancers, infectious diseases, and rare genetic conditions, AIBN researchers are using organoids to transform our approach to addressing the world’s most serious health problems.

Molecular sensor: Developing our patented ‘molecule chips’

AIBN researchers are revolutionising the way we understand, diagnose and treat disease by creating nanotechnologies that can detect and manufacture molecules on a single wafer thin chip.

Uncontrolled bleeding: Snake venom to save lives

AIBN researchers are using venom from two of the world’s deadliest snakes to save lives by stopping uncontrolled bleeding.

What we learned about ALS from the metabolic data of 600 people

Published on: 15 April 2024

What can the metabolism of 606 people from China, the Netherlands and Australia tell us about the onset and progression of ALS? Turns out, quite a bit.

AIBN's researchers are examining individual molecules, manufacture proteins and use the study of bioinformatics to develop treatments getting them from the lab bench to the clinic more quickly than ever.